The naturally occurring sex difference in dendritic spine number on hypothalamic neurons offers a unique opportunity to investigate mechanisms establishing synaptic patterning during perinatal sensitive periods. A major advantage of the rat as a model of sexual differentiation is that treatment of neonatal females with estradiol will permanently induce the male phenotype. During the development of other systems, exuberant innervation is followed by activity-dependent pruning necessary for elimination of spurious synapses. In contrast, we demonstrate that estradiol-induced organization in the hypothalamus involves the induction of new synapses on dendritic spines. Activation of estrogen receptors by estradiol triggers a nongenomic activation of PI3 kinase that results in enhanced glutamate release from presynaptic neurons. Subsequent activation of ionotropic glutamate receptors activates MAP kinases, thereby inducing dendritic spine formation. These results reveal a transneuronal mechanism by which estradiol acts during a sensitive period to establish a profound and lasting sex difference in hypothalamic synaptic patterning.
INTRODUCTION
Determining the mechanisms underlying the formation of functional neuronal circuits is central to understanding brain development. Variation in neuronal activity, hormonal milieu, or environmental cues can permanently change the formation of specific circuits and the phenotype of individual neurons during a developmental sensitive period. This concept is well established in the visual cortex (Desai et al., 2002; Wong, 1999; Zhang and Poo, 2001) , motor neuron circuits (Hanson and Landmesser, 2004; Haverkamp and Oppenheim, 1986) , and the song control circuit in birds (Iyengar and Bottjer, 2002) , in which light, movement, or sound, respectively, affect spontaneous activity in the neurons and in so doing establish the proper synaptic connections for optimal function. Appropriate synaptic connections must also be achieved in male and female brains wherein fundamental neuronal differences mediate the well-known sex differences in physiology and behavior. In rodents, these sex differences are determined during a critical period of development by estradiol, which is aromatized from testicular androgens in the male (Naftolin et al., 1971) . Early estradiol exposure permanently differentiates the male from the female rodent brain by establishing sex differences in synaptic connections and neuronal morphology that affect behavior (De Vries and Simerly, 2002; McCarthy, 2008) .
Dendritic spines are anatomical loci of excitatory synapses on neurons. Spine formation and maintenance are sensitive to both electrical and chemical stimulation. Estradiol is an important regulator of dendritic spines in many brain regions during development (Amateau and McCarthy, 2002b; Arai, 1980, 1986b; Pozzo Miller and Aoki, 1991; Todd et al., 2005) and adulthood (Calizo and Flanagan-Cato, 2000; Carrer and Aoki, 1982; Murphy and Segal, 1996; Woolley and McEwen, 1992) , thereby influencing behavior and reproductive function. In newborn rats, males have twice the number of dendritic spines on hypothalamic neurons as females, and treatment of females at birth with testosterone, which is centrally aromatized to estradiol in the brain, increases the number of dendritic spines to that of males (Todd et al., 2007) . However, the mechanism or mechanisms by which estradiol permanently organizes a sex difference in dendritic spines in the medial basal hypothalamus (MBH) remain unknown.
The classic model of estradiol action involves ligand binding to a nuclear receptor, dimerization and recruitment of coactivators, and initiation of gene transcription at estrogen response elements (ERE) found in the promoter region of estrogen-responsive genes. Estrogen receptors (ER) are members of a superfamily of nuclear transcription factors that regulate gene expression (Beato, 1989; Uht et al., 1997) . Dense concentrations of ER are found in neonatal hypothalamic neurons of males and females (Shughrue et al., 1997; Simerly et al., 1990) and are directly linked to sexual differentiation of the brain (McCarthy et al., 1993; McEwen et al., 1977; Quadros et al., 2002) . Activated ER can also indirectly promote gene transcription independent of EREs via activation of kinases that in turn activate specific promoter elements. In the hypothalamus, ligand-bound ER activates protein kinase A (PKA), CREB (Abraham and Herbison, 2005; Aronica et al., 1994; Lee et al., 2004; Zhou et al., 1996) , the mitogen-activated protein kinase (MAP kinase) MEK 1/2 (Singh et al., 1999) , and phosphatidylinositol 3-kinase (PI3 kinase) (Znamensky et al., 2003) . Thus, ER activation can be localized to the membrane, yet induce a host of effects that induce or facilitate transcriptional activity dependent on or independent of the ERE (Vasudevan and Pfaff, 2007) . To date, membrane-initiated effects of estradiol have not been reported in the developing brain, and in fact would seem unlikely given that rapid membrane effects are presumed to be not conducive to permanent organizational changes. We now report that estradiol promotes spine formation in the developing hypothalamus via rapid, nongenomic activation of PI3 kinase in presynaptic neurons, enhancing glutamate release and glutamate receptor activation in postsynaptic neurons. AMPA-and NMDA-receptor-dependent activation of postsynaptic MAP kinases then triggers a protein synthesis-dependent increase in dendritic spine number.
RESULTS
Estradiol and NMDA Receptor Activation Increase Dendritic Spine Number in the Developing Hypothalamus to Establish a Sex Difference On the day of birth, males had significantly more dendritic spines on Golgi-Cox impregnated hypothalamic neurons than females (main effect F 3,19 = 8.80, p = 0.0007, post hoc p = 0.001; Figure 1A) . Treatment of females with estradiol or NMDA for 6 hr significantly increased the number of spines compared with that of vehicle-treated females (p = 0.001) to levels equivalent with those seen on male neurons. Further analysis of the Golgi-Cox impregnated neurons revealed that the increase in spine number was accompanied by an elongation of neuronal dendrites of 34% (F 3,19 = 3.47, p = 0.036; Figure 1A ). There was no difference in the density of dendritic spines (data not shown).
Newborn males also had significantly more spinophilin protein in the MBH than females, as determined by western blot analysis, confirming the previously reported correlation between increased dendritic spine number and increased spinophilin levels McCarthy, 2002a, 2004; Todd et al., 2005 Todd et al., , 2007 . Treatment of females with estradiol (250 mg) increased spinophilin levels to those of males within 6 hr (F 2, 15 = 15.8, p = 0.002; Figure 1B ). To determine whether the effect of estradiol on dendritic spines at 6 hr was maintained at later time points, brains were also collected from animals 48 hr after a single injection of estradiol. Spinophilin levels remained significantly elevated 48 hr after estradiol treatment compared with those of control (F 3,20 = 4.09, p = 0.031; Figure 1C ) and were not different from 6 hr of estradiol exposure (p = 0.901), confirming that estradiol-induced dendritic spines are maintained for an extended period of time. The MBH is thus sexually dimorphic at birth with regard to spinophilin level and spine number, and the levels seen in males can be induced in females by treatment with estradiol or activation of NMDA receptors.
Estradiol Increases Dendritic Spine Number in the Developing Hypothalamus via Activation of Ionotropic Glutamate Receptors
We hypothesized that activation of glutamate receptors is necessary for the estradiol-induced increase in dendritic spine number in the developing hypothalamus. We first treated animals with the AMPA-type glutamate receptor antagonist NBQX (2.5 mg subcutaneously [s.c.]) prior to estradiol treatment; NBQX prevented the estradiol-induced increase in spinophilin (F 3,17 = 7.04, p = 0.002; Figure 2A ). Treatment with NBQX alone had no effect. To determine if NMDA receptors are also required for estradiol-induced spinophilin, animals were pretreated with the NMDA receptor antagonist MK801 (10 mg s.c.) prior to estradiol treatment. MK801 completely blocked the estradiol-induced increase in spinophilin (F 3,13 = 13.29, p = 0.0003; Figure 2A ). Treatment with MK801 alone had no effect on spinophilin levels.
These results suggest that NMDA receptor activation is necessary for estradiol to induce dendritic spines. The ability of NMDA treatment in vivo to increase dendritic spines detected by Golgi impregnation suggested that NMDA glutamate receptor activation is sufficient as well. We further confirmed this by treatment of female pups on the day of birth with estradiol, NMDA (10 mg s.c.), or vehicle. Direct activation of NMDA receptors mimicked the effect of estradiol on spinophilin levels (F 2,20 = 7.70, p = 0.002; Figure 2B ). These data confirm the NMDA-mediated increase in dendritic spines seen using Golgi impregnation of VMN neurons ( Figure 1A ) and are consistent with previous reports indicating that activation of AMPA receptors also increases dendritic spines in the developing female hypothalamus to the same degree as estradiol (Todd et al., 2007) . We conclude that estradiol does not induce increases in spinophilin protein directly, but rather does so indirectly in a glutamate-receptordependent manner. Furthermore, activation of glutamate receptors is not only necessary but also sufficient to induce sex differences in dendritic spine number in the developing hypothalamus.
Estradiol Has No Effect on the Number or Function of Glutamate Receptors in the Developing Hypothalamus
The pivotal observations from the previous experiments suggest that activation of AMPA and NMDA receptors is required for estradiol-induced increases in dendritic spine number. There are two potential mechanisms by which this could occur: (1) estradiol might alter the number or function of postsynaptic AMPA and/or NMDA receptors, or (2) estradiol might act presynaptically to promote glutamate release directly from hypothalamic neurons.
To test the first hypothesis, male and female hypothalami were assessed by quantitative western blot for levels of the AMPA receptor subunits GluR1 and GluR2 and the requisite NMDA subunit, NR1. There was no sex difference in, and no effect of estradiol treatment on, the amount of GluR1 (F 2,18 = 0.378, p = 0.690), GluR2 (F 2,16 = 0.488, p = 0.623), or NR1 (F 2,14 = 0.788, p = 0.474) in the neonatal MBH ( Figure S1A , available online).
In another experiment females were treated with or without estradiol (100 mg/0.1 ml sesame oil, s.c.) on postnatal day 0 (PN0), 1, and 2. Slices were made from the hypothalamus of these animals on PN4-5, and AMPA-mediated miniature excitatory postsynaptic currents (mEPSCs) were recorded from ventrolateral VMN (vlVMN) neurons. Estradiol-induced dendritic spines are fully established at this age (Matsumoto and Arai, 1986a) (Figure 3B ). We found no significant effect of estradiol on the median amplitude (t 16 = À0.87, p = 0.238), frequency (t 16 = À1.22, (A) Golgi-Cox impregnated neurons were morphologically assessed (representative photomicrographs in left panels, scale bar = 10 mm). As shown in the right panels, males had significantly more dendritic spines per dendrite and dendrites were significantly longer than those in females on the day of birth (ANOVA F 3,19 = 8.8; *p < 0.005 compared with all other groups). (B) (Left) A coronal schematic of the rodent brain is shown in the middle left panel (Paxinos and Watson, 2004) . The rectangle indicates the outline of the medial basal hypothalamus (MBH) dissection. (Right) Western blot for spinophilin indicates that males had higher levels than females on the day of birth, and treatment of females with estradiol (E 2 ) increased spinophilin to levels seen in males within 6 hr (ANOVA F 3,19 = 3.47; *p < 0.05 compared with all other groups; n = 5-6 per group). (C) MBH tissue was collected at 6 or 48 hr post-estradiol (E 2 ). Spinophilin was significantly elevated at both time points compared with that of controls (ANOVA F 3,20 = 4.09; *p < 0.05; n = 5-6 per group). There was no difference in spinophilin levels between vehicle-treated animals at 6 hr versus 48 hr (p = 0.90), and these were collapsed into one group. Graphical representation of dendritic spine and western blot analysis indicates the mean ± SEM for each treatment group. p = 0.396), or decay time (t 16 = À0.57, p = 0.572) of mEPSCs in the developing hypothalamus (n = 8-10 cells from vehicletreated or estradiol-treated animals; Figure 3A ). We conclude that estradiol has no effect on the number of synaptic AMPAtype glutamate receptors in these neurons. We also found no effect on the computed ratio of synaptic AMPA-to-NMDA receptors, seen by measuring the peak amplitude of EPSCs mediated by AMPA receptors and the amplitude of the NMDA-receptormediated component of the EPSC (p = 0.8, n = 7 cells from each; ( Figure 4A ). Estradiol also had no effect on glutamateinduced calcium responses in cultured hypothalamic neurons, as measured with the fluorescent ratiometric calcium-sensitive dye fura-2. We found no difference in either the number of neurons that responded to glutamate (c 2 = 1.65, p = 0.200) or the peak amplitude of the calcium response to glutamate (K-S test: c 2 = 2.12, p = 0.697, Figure S1B ).
Recorded neurons were filled with biocytin from a patch pipette and their morphology was analyzed. Consistent with the morphological analysis of Golgi-Cox impregnated neurons ( Figure 1A ), neurons treated with estradiol had more dendritic spines along the primary dendrite compared with those of control (t 7 = 2.67, p = 0.031), and the overall length of the dendrite was greater (t 7 = 2.41, p = 0.060; Figure 3B ). There was no effect of estradiol on the number of branches per dendrite or the dendritic spine density (data not shown). (A) (Left) Estradiol (E 2 ) treatment induced a 3-fold increase in spinophilin, and pretreatment with the AMPA receptor antagonist NBQX completely blocked the increase (ANOVA F 3,17 = 7.04; *p < 0.05, compared with all other groups, n = 5-6 group). (Right) In a separate experiment, estradiol again significantly increased spinophilin, and pretreatment with the NMDA receptor antagonist MK801 also completely prevented the increase (ANOVA F 3,13 = 13.29; *p < 0.05 compared with all other groups, n = 5-6 per group). (B) Treatment of females on the day of birth with either estradiol or NMDA to directly activate NMDA receptors significantly increased spinophilin levels within 6 hr (ANOVA F 2,20 = 7.70; *p < 0.05 compared with vehicle [Veh]; Veh: n = 9, E 2 : n = 9, NMDA: n = 5). Graphical representation of western blot analysis indicates the mean ± SEM for each treatment group.
Estradiol Enhances Presynaptic Neurotransmitter Release from Glutamatergic Terminals of Developing Hypothalamic Neurons
Concluding that estradiol does not affect glutamatergic transmission postsynaptically, we hypothesized that estradiol promotes presynaptic glutamate release to increase dendritic spines. To test this hypothesis, we measured whole-cell voltage-clamp recordings to compare the paired-pulse ratio (PPR) in brain slices from female pups treated with or without estradiol for up to 6 hr on PN2. The PPR is inversely correlated with release probability (Zucker and Regehr, 2002) . The amplitude of the AMPA-receptor-mediated EPSC elicited in response to the second of two stimuli delivered at an interstimulus interval of 50 ms was considerably facilitated compared with the first EPSC in cells in vehicle-treated slices (PPR = 1.85 ± 0.21, n = 11). In cells from estradiol-treated slices, the amplitude of the second EPSC was also facilitated, but to a significantly smaller extent (PPR = 1.22 ± 0.09, n = 12) (t 21 = À2.72, p = 0.0127; Figure 4A ). The decrease in the PPR in the estradiol-treated slices is consistent with an estradiol-induced increase in the probability of release at glutamatergic synapses.
We next used the fluorescent styryl dye FM4-64 to assay the effects of estradiol on release probability more directly. Presynaptic boutons were labeled with FM4-64 and the probability of transmitter release was assayed by the rate of FM4-64 destaining in response to either KCl-induced depolarization or electrical field stimulation (Brager et al., 2003; Pyle et al., 1999; Ryan et al., 1996) (Figure S2 ). Post hoc analysis of hypothalamic neurons revealed 100% colocalization of FM4-64 staining and vesicular glutamate transporter 2 (VGLUT2) immunostaining, indicating the terminals analyzed for transmitter release were glutamatergic (vehicle: n = 32 boutons; estradiol: n = 36 boutons from two separate cultures; Figure 5A ).
Neuron E 2 Increases Spines by Enhancing Glutamate Release
Treatment of hypothalamic neurons with estradiol for only 3 hr significantly increased the total fluorescence lost after 30 s of depolarization with either 50 mM KCl or stimulation at 1 Hz via an electrode positioned near the imaged region, compared with untreated cultures (F 3,16 = 3.94, p = 0.027; Figure 5B ). After 120 s of depolarization, the total fluorescence lost for all groups was not significantly different (p = 0.223), indicating that the size of the recycling vesicle pool was not affected by estradiol.
Treatment with the ER antagonist ICI 182,780 (i.e. ICI) alone had no effect on the rate of destaining (p = 0.239; Figure 5C ) but completely prevented estradiol-induced enhancement of FM4-64 destaining (F 3,7 = 6.29, p = 0.032), indicating that estradiol-enhanced glutamate release requires activation of the ER.
There was no effect of estradiol treatment on the density of FM4-64-labeled boutons (F 3,25 = 0.86, p = 0.470) or the area of these boutons (F 3,25 = 0.26, p = 0.850) compared to that of controls ( Figure S3 ).
When analyzed separately, neurons treated with estradiol for less than 2 hr showed an increase in neurotransmitter release when compared with those that underwent vehicle treatment (A) (Left) Representative traces of mEPSCs recorded from neurons in the VMN treated with or without estradiol for 2 days beginning at birth and the corresponding cumulative probability plot (n.s., K-S test). (Right) Estradiol treatment had no effect on the median amplitude (pA) (t 16 = À0.87; p = 0.238), frequency (Hz) (t 16 = À1.22; p = 0.396), or the decay time (ms) (t 16 = À0.57; p = 0.572) of mEPSCs recorded from these neurons (n = 8-10 neurons). (B) Representative photomicrographs of an MBH slice used for recording mEPSCs from ventrolateral VMN (vlVMN). Arrow indicates a neuron filled with biocytin after recording. ARC, arcuate nucleus; III, the third ventricle. Images immediately to the right show representative neurons that were recorded from and then filled with biocytin. (Lower panels) Morphological analysis of biocytin-filled neurons in slices from females treated with estradiol for 48 hr at birth revealed an increased number of dendritic spines along the primary dendrite (t 7 = 2.67; *p < 0.05 compared with vehicle [Veh] ) and increased total dendrite length (t 8 = 2.41; *p < 0.05 compared with vehicle; Veh: n = 4 neurons, estradiol: n = 6 neurons). Graphical representation of mEPSC and morphological analysis indicates the mean ± SEM for each treatment group.
for the same amount of time (p = 0.05; Figure 5C inset), demonstrating that estradiol rapidly enhances the release of glutamate from developing hypothalamic neurons via activation of classical ER. Notably, the increase in release probability within 2 hr precedes the increase in the number of dendritic spines, first detectable at 6 hr, and the activation of MAP kinase (see below), which is not detectable until 3 hr post-estradiol.
Estradiol-Enhanced Glutamate Release Does Not Require Protein Synthesis but Does Require Activation of PI3 Kinase
The rapid effect of estradiol on glutamate release from hypothalamic neurons suggested a nongenomic mechanism of action. Using 30 mM cycloheximide (CHX) to block RNA translation, we tested whether estradiol-enhanced neurotransmission required synthesis of new proteins. Blocking protein synthesis had no effect on estradiol-enhanced FM4-64 destaining in cultured hypothalamic neurons after 3 hr (F 3,24 = 3.66, p = 0.67; vehicle: n = 8, E 2 : n = 8, CHX + E 2 : n = 8, CHX: n = 4 coverslips); however, CHX treatment did block the estradiol-induced increase in spinophilin protein (F 3,18 = 3.17, p = 0.0498; vehicle: n = 6, E 2 : n = 6, CHX + E 2 : n = 6, CHX: n = 4 coverslips; Figure 6A ), confirming effective inhibition of protein synthesis and a requirement for protein synthesis in the promotion of spine formation. We conclude that estradiol can enhance neurotransmitter release by activating ER; however, the enhancement does not require the synthesis of new proteins.
A time course analysis of phosphorylation of the PI3 kinase substrate Akt at ser473, using western blot, indicated that estradiol rapidly activated PI3 kinase within only 1 hr (F 5,21 = 3.89, p = 0.048; Figure 6B ), and that this activation was maintained at 3 hr and 6 hr after estradiol treatment (p = 0.038 and p = 0.0247, respectively; n = 4-5 coverslips for each group). The activation of PI3 kinase by estradiol therefore just precedes the enhancement of glutamate release, which occurs at 2-3 hr after treatment, suggesting that it may underlie the increase in release probability. We tested this hypothesis by blocking PI3 kinase activation with the specific inhibitor LY294002 (10 mM) and found that it completely prevented estradiol-enhanced neurotransmitter release (F 3.22 = 3.91, p = 0.023; vehicle: n = 7, E 2 : n = 7, LY + E 2 ; n = 8, LY: n = 4 coverslips; Figure 6B ). If enhanced glutamate release via estradiol-induced activation of PI3 kinase is necessary for increasing dendritic spine number, then blocking estradiolenhanced glutamate release with LY294002 would also block the ability of estradiol to increase dendritic spines in these neurons. As predicted, application of LY294002 also blocked estradiol-induced formation of dendritic spines as determined by western blot for spinophilin (F 3,15 = 4.39, p = 0.003; n = 4-5 coverslips per group; Figure 6B ).
These pharmacological experiments, taken together with the time course of events, are consistent with a model in which estradiol acts via ER to activate PI3 kinase via a nontranscriptional mechanism, and PI3 kinase activation enhances presynaptic glutamate release, thereby increasing postsynaptic AMPA and NMDA receptor activation to induce spine formation.
Estradiol-Induced Glutamate Release Activates MAP Kinase in the Postsynaptic Neuron to Increase Dendritic Spines We also determined that estradiol activates the MAP kinase MEK 1/2, as seen by phosphorylation of its substrate ERK 1/2, just prior to the estradiol-induced increase in spinophilin ( Figure 7A ). By 3 hr post-estradiol treatment, there was significant activation of MEK 1/2 (F 2,12 = 6.60, p = 0.042) that was not seen at 1 hr but . Estradiol had no effect on the ratio of AMPA (recorded at a holding potential of À80 mV) to NMDA (recorded at +40 mV) currents (t 12 = À0.24; p = 0.81; Vehicle [Veh]: n = 7, E 2 : n = 7). (B) In the same neurons, EPSCs elicited with pairs of stimuli (interstimulus interval = 50 ms, holding potential = À80 mV) indicated that estradiol pretreatment significantly decreased the pairedpulse ratio (amplitude of second EPSC divided by amplitude of first EPSC), consistent with an increase in the probability of glutamate release after estradiol treatment (t 21 = À2.72; *p < 0.05 compared with vehicle). Graphical representation of electrophysiological analysis indicates the mean ± SEM for each treatment group.
was maintained for up to 6 hr after estradiol (p = 0.002; Figure 7C ). This time course suggests that activation of MAP kinase by estradiol occurs at a point after the enhanced release of glutamate, and that estradiol-induced activation of MAP kinase occurs downstream of glutamate receptor activation to induce dendritic spine formation. This led to the prediction that blocking MAP kinase would have no effect on estradiol-enhanced neurotransmitter release in hypothalamic neurons, and indeed blocking MAP kinase with PD98059 had no effect on estradiol-enhanced FM4-64 destaining (F 3,22 = 6.67, p = 0.169; vehicle: n = 7, E 2 : n = 7, PD + E 2 : n = 8, PD: n = 4 coverslips; Figure 7A ).
Earlier experiments revealed that treatment of females with the glutamate receptor antagonists NBQX or MK801 completely blocked estradiol-induced increases in spinophilin (see Figure 2 ). In the same animals, NBQX treatment also completely blocked the estradiol-induced activation of MAP kinase (F 3,17 = 2.96, p = 0.041; Figure 7B ). We determined that treatment with MK801 also prevented activation of MAP kinase by estradiol in vivo (F 3,17 = 4.79, p = 0.013; Figure 7B ). Neither NBQX nor MK801 treatment alone affected basal levels of MAP kinase. These data confirm that activation of MAP kinase occurs downstream of glutamate receptor activation in the developing hypothalamus.
To determine if MAP kinase activity was required for the effect of estradiol on dendritic spines, animals were pretreated with PD98059 (200 ng intracerebroventricularly [ICV] ). Indeed, PD98059 blocked both the estradiol-induced activation of MAP kinase (F 3,16 = 7.91, p = 0.002; Figure 7C ) and the increase in spinophilin protein within 6 hr (F 3,16 = 12.8, p = 0.002; Figure 7C ). PD98059 treatment alone had no effect on spinophilin, indicating that MAP kinase activity is not required to maintain basal spinophilin levels in the MBH.
We also determined that estradiol promoted an increase in spinophilin protein in cultured hypothalamic neurons generated from E18 embryos and assayed on day in vitro 5 (DIV5) (Figure S4A) . We used this in vitro model to test the role of other kinases in the estradiol-induced increase in spinophilin. We found that blocking MEK 1/2 or the c Jun kinase (JNK) Figure S4B ) and increase in dendritic spines (F 4,19 = 8.38, p = 0.005; Figure S4C ). Blocking activation of p38 MAP kinase, also located in the hypothalamus, had no significant effect on estradiol-induced ERK 1/2 activation (p = 0.936) or levels of spinophilin (p = 0.074). In addition, blocking PKA (p = 0.130), protein kinase C (PKC) (p = 0.067), and Cam Kinase II (CamKII) (p = 0.430) had no significant effect on estradiol-induced spinophilin in the hypothalamic neurons ( Figure S5 ). We conclude that activation of glutamate receptors at a time after which estradiol enhances glutamate release is necessary for estradiol-induced activation of at least two MAP kinases, MEK 1/2 and JNK, and possibly more. Consequently, activation of multiple MAP kinases is a necessary component of estradiol-induced dendritic spines in the developing hypothalamus.
Enhancing Neurotransmitter Release with a-Latrotoxin Mimics the Effect of Estradiol Treatment on Spinophilin Levels
If estradiol promotes dendritic spine formation by enhancing glutamate release from developing hypothalamic neurons, then direct enhancement of neurotransmitter release should mimic the effects of estradiol and increase spinophilin levels in MBH neurons. To test this prediction, we treated cultured hypothalamic neurons with estradiol (10 nM) as a positive control; the estrogen receptor antagonist ICI (1mm) with or without estradiol; or a-latrotoxin (3 pM). Latrotoxin is a secretagogue that at low concentrations stimulates neurotransmitter release by facilitating the presynaptic exocytotic machinery (Capogna et al., 1996) . As seen previously, there was an overall effect of treatment on spinophilin levels in hypothalamic neurons (F 4,20 = 9.86, p = 0.001; Figure 8A ). Specifically, treatment of neurons with estradiol significantly increased spinophilin compared with controls (p = 0.001, n = 5-6 coverslips). Pretreatment with ICI blocked the estradiol-induced increase in spinophilin (p = 0.007 compared with estradiol-treated), but had no effect on basal spinophilin (p = 0.439). Stimulation of glutamate release with a-latrotoxin induced an increase in spinophilin similar to that observed in estradiol-treated cultures (p = 0.68), under conditions in which we demonstrated that ER were fully blocked by ICI. With ER fully blocked, a-latrotoxin increased spinophilin levels to those seen with estradiol treatment. This experiment provides positive evidence that enhanced glutamate release alone is sufficient to promote the formation of new dendritic spines in the developing hypothalamus, and rules out any possible permissive postsynaptic role for ER activation in the induction of dendritic spines, suggesting a completely presynaptic mechanism of estrogen action. In a separate experiment, we also observed that combined a-latrotoxin and estradiol treatment induced an increase in spinophilin expression (F 3,26 = 3.65 main effect) that was not different from the increase induced by either alone (p = 0.221 and p = 0.220; Figure 8B ), suggesting that a-latrotoxin occludes the effect of estradiol on hypothalamic neurons. Therefore, enhancing neurotransmitter release is sufficient to increase dendritic spines on developing hypothalamic neurons.
DISCUSSION
A major role of steroids in the adult brain is modulation of neuronal plasticity, with an increasing emphasis on rapid but transient effects (Balthazart and Ball, 2006) . In marked contrast, estradiol action in the developing brain permanently organizes the neural substrate, making a rapid membrane-initiated effect an unlikely mechanism by which this end would be achieved. To our surprise, we have found that the initial event in estradiol-mediated organization of dendritic spine synapses of the developing hypothalamus begins with a transcription-independent activation of PI3 kinase within 1 hr of steroid exposure, as demonstrated by an increase in the phosphorylation of its substrate, Akt. The activation of PI3 kinase was maintained for at least 6 hr under continuous estradiol exposure, as would be found in the developing brain.
Consequent to PI3 kinase activation, we observed estradiolenhanced glutamate release from hypothalamic neurons both in acutely prepared hypothalamic brain slices, as seen by a reduced PPR, and in primary cell cultures, as seen by examining the release of FM4-64 from presynaptic terminals. Application of a depolarizing stimulus, such as KCl or 1 Hz electrical stimulation, evoked calcium-dependent neurotransmitter release and destaining of FM4-64 from boutons that was significantly faster in neurons incubated with estradiol for only 2-3 hr prior to application of the depolarizing stimulus, compared with vehicle-treated cultures. This action of estradiol on synaptic excitation was entirely presynaptic; we detected no change in the number or function of postsynaptic glutamate receptors.
Estradiol-enhanced glutamate release required activation of PI3 kinase. Phosphoinositides are a key component of the membrane and their phosphorylation, by PI3 kinase, produces a signaling molecule important for the recruitment and phosphorylation of other proteins at the membrane (Cremona and De Camilli, 2001; Di Paolo and De Camilli, 2006; Toker and Cantley, 1997) . As a result, they play an important role in the processes of exocytosis, endocytosis, and trafficking of vesicles at the presynaptic membrane (Cousin et al., 2003; Lin et al., 2001; Opazo et al., 2003; Yokomaku et al., 2003) . Though the exact mechanism of action remains unknown, phosphoinositides appear to act as a critical regulatory component of neurotransmitter release. We found that PI3 kinase inhibition did not block all neurotransmitter release, suggesting that its role in estradiol-enhanced glutamate release may be to facilitate the fusion of synaptic vesicles to the target membrane (Rizzoli and Betz, 2002) , via either changes in the dynamics of the membrane itself or phosphorylation of the proteins necessary for vesicle fusion (Cousin et al., 2003) . PI3 kinase might also enhance glutamate release by facilitating the mobilization of calcium into the terminal (Gong et al., 2005; Holt et al., 2003; Mori et al., 2004) . We conclude that the role of PI3 kinase in glutamate release appears to be specific, because inhibition of MAP kinase had no effect on estradiol-enhanced glutamate release; and blocking PKA, PKC, and CamKII had no effect on estradiol-induced spinophilin. Moreover, there was no effect of the protein synthesis inhibitor CHX on estradiolenhanced glutamate release, suggesting that the activation of PI3 kinase by estradiol was due to a direct interaction between the two proteins, presumably in the presynaptic membrane. 
Neuron
The estradiol-enhanced glutamate release and glutamate receptor activation led to the activation of postsynaptic MAP kinases, as demonstrated by increased phosphorylation of ERK 1/2. This effect was delayed compared with the activation of PI3 kinase, requiring at least 3 hr of estradiol exposure to become apparent, further confirming the temporal sequence of events. Blocking ionotropic glutamate receptors prevented activation of MAP kinase in response to estradiol, and inhibition of the MAP kinases MEK 1/2 and JNK, but not p38 MAP kinase, prevented the estradiol-mediated increase in spine number, leading to the conclusion that activation of multiple MAP kinases in the postsynaptic neuron is a consequence of enhanced glutamate receptor activation and not the result of a direct activation by the ER. Inhibiting MAP kinase prevented the estradiol-induced increase in spinophilin, establishing a causal role of these enzymes in new spine construction in this system. Phosphorylation of ERK is implicated in the reorganization of actin filaments and is therefore capable of altering numerous cellular endpoints including the targeting of mRNA to dendritic spines (Huang et al., 2007) , BK channel activation (O'Malley and Harvey, 2007) , and AMPA receptor reorganization at the spine (Kim et al., 2005; Rumbaugh et al., 2006) .
The observation that estradiol-induced signaling in the postsynaptic neuron does not involve direct actions of the ER highlights an emerging role for cell-to-cell communication in steroid-mediated organization of the developing brain. Advances in the mechanism of sexual differentiation of the Drosophila brain highlight the importance of a single gene, fruitless (fru) (Manoli et al., 2005) , and further demonstrate that fru acts in a cell-autonomous manner to selectively change the morphology of individual neurons that express the protein (Kimura et al., 2005) . One might predict, given the restricted distribution and expression of steroid receptors, that a similar potential exists in the mammalian brain. Both the current results and our previous findings establish that this is not the case. In the preoptic area (POA), another brain region subject to estradiol-mediated organization of synaptic patterning, the initiating event is increased production of prostaglandin E2 (PGE2) following upregulation of the enzyme COX-2 (Amateau and McCarthy, 2004) . Drawing on observations that PGE2 induces glutamate release from astrocytes (Bezzi et al., 1998 ), a working model proposes that in the POA the prostaglandin is released from the neuron and acts upon neighboring astrocytes to induce glutamate release, which in turn acts back on neurons to activate AMPA receptors and induce the formation of dendritic spines. Therefore, in this brain region, neuronal-astrocytic-neuronal communication is essential. Similarly, neurons in the arcuate nucleus of the hypothalamus undergo estradiolmediated sexual differentiation that begins in neurons with an increase in GABA synthesis via upregulation of glutamic acid decarboxylase (GAD) (Mong et al., 2002) . GABA is released from the neurons, presumably nonsynaptically, and activates GABA A receptors on neighboring astrocytes and induces growth and branching of glial processes, i.e., stellation. Through mechanisms that remain poorly understood, the differentiated astrocyte communicates back to the neurons and suppresses the formation of new dendritic spines. Thus, in three circumstances in the mammalian brain in which the cellular mechanisms establishing sex differences in synaptic patterning have been well characterized, there is a defined role for cell-to-cell communication (McCarthy, 2008) . The consequence of this mode of differentiation is the potential for steroid-mediated differentiation of neuronal morphology to extend beyond those cells that contain steroid receptors and to coordinate the organization of a more extensive region of the neuropil. As a result, the optimal neural circuitry necessary to integrate sensory and physiological stimuli for maximum reproductive fitness is obtained.
EXPERIMENTAL PROCEDURES Animals
Female Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) maintained on a reverse 12 hr light/dark cycle and provided ad libitum food and water were mated in our animal facility, and pregnancy was confirmed by presence of sperm in a vaginal smear. Pregnant females were isolated and allowed to deliver normally. Cages were checked regularly for presence of pups to determine the time and day of birth (PN0). All animal experiments were approved by the University of Maryland School of Medicine Institutional Animal Care and Use Committee.
Drugs
All drugs were purchased from Sigma unless otherwise noted. The steroid 17b-estradiol (250 mg) was dissolved in ethyl oleate, which allows rapid release. NBQX disodium salt was dissolved (2.5 mg/0.05 ml) in 0.9% saline. MK801 was dissolved (10 mg/0.05 ml) in 0.9% saline. N-methyl-D-aspartate was dissolved (10 mg/0.05 ml) in 0.9% saline. Biocytin was obtained from Molecular Probes. PD98059 (Calbiochem) was dissolved (100 ng/ml) in 2% DMSO for ICV injections.
Treatment of Pups
Estradiol and vehicle were injected s.c., and PD98059 was infused ICV 30 min prior to treatment with estradiol or its vehicle. ICV infusions were performed by penetrating the skin and skull with a beveled 23 gauge 1 ml Hamilton syringe stereotaxically lowered to a predetermined depth of 2 mm before infusion of 1 ml over a 60 s period in cryoanesthetized animals. NBQX, MK801, NMDA, and saline injections were given s.c. immediately before estradiol and again blot analysis for spinophilin protein indicates 30 mM CHX is a sufficient dose to block the synthesis of new proteins, including the estradiol-induced increase in spinophilin seen 6 hr after treatment. (ANOVA F 3,18 = 3.17; *p < 0.05 compared with all other groups). This further confirms that the estradiol-induced increase in spinophilin is downstream of nongenomic enhancement of glutamate release (Veh: n = 6, E 2 : n = 6, CHX + E 2 : n = 8, CHX: n = 4 coverslips). Treatment with estradiol for 3 hr increased the rate of FM4-64 destaining in response to a depolarizing stimulus, and pretreatment with PD98059 had no effect on estradiol-enhanced destaining (ANOVA F 3,22 = 6.67; *p < 0.05 compared with vehicle and PD; Veh: n = 7, E 2 ; n = 7, PD + E 2 : n = 8, PD: n = 4 coverslips). (Right) Estradiol treatment significantly increased activation of MAP kinase within 3 hr, as seen by the Neuron 4 hours after estradiol injection. Exactly 6 hr after treatment, animals were euthanized and the MBH was isolated ( Figure 1B ).
Golgi-Cox Impregnation and Biocytin Analysis PN0 rats were separated and treated according to the following groups: (1) males + vehicle, (2) females + vehicle, (3) females + 250 mg 17b-estradiol and (4) females + 10 mg NMDA. Six hours after treatment, brains were collected and processed for Golgi impregnation as previously described (Mong et al., 1999; Todd et al., 2007) . After processing of both Golgi and biocytin-filled neurons, five neurons from each were analyzed for the number of dendritic spines (>5 mm) on each primary dendrite and the length of the primary dendrite (including all branch lengths extending from that dendrite). Data were analyzed with one-way ANOVA, a < 0.05, and Tukey's post hoc when appropriate.
Western Immunoblot
Brain tissue from treated animals and hypothalamic cultures was homogenized in lysis buffer and prepared as described previously (Amateau and McCarthy, 2002a; Todd et al., 2007; and details provided in Supplementary Methods.) Whole-Cell Patch-Clamp Recordings and Hypothalamic Brain Slice Preparation For evoked excitatory postsynaptic currents (eEPSC), female pups were treated on PN2 with estradiol (250 mg/0.1 ml ethyl oleate) or vehicle and collected 6 hr later. For mEPSCs, female rat pups were treated with estradiol (100 mg/0.1 ml) or vehicle once a day each day from PN0 to PN2 and collected on PN4-5. Coronal hypothalamic slices (400 mm) containing the VMN region ( Figure 3B ) were prepared using a Vibratome (Vibratome series 1000, St. Louis, MO) in ice-cold sucrose solution, where NaCl in the artificial cerebral spinal fluid (ACSF) was replaced by an isosmotic concentration of sucrose. Slices were then incubated at 34 C for 20 min, and then allowed to recover for at least 1 hr at room temperature (RT) before experimentation. For evoked EPSCs, vehicle (DMSO 0.01%) or estradiol (10 nM) was included in the ACSF solution during slice preparation and recordings in vehicle-pretreated or estradiol-pretreated animals, respectively. The osmolarity of all solutions used was 305-315 mOsm. Details regarding the recording of eEPSCs and mEPSCs can be found in the Supplemental Methods.
Electrophysiological Data Analysis
Cumulative probability distributions of mEPSC amplitude were created either from control or treated cells. Evoked EPSC amplitude was computed from an average of ten consecutive responses. The amplitude of NMDA-receptormediated currents, recorded with the cell voltage-clamped at +40 mV, were collected at 60 ms following the stimulation, a time at which AMPA-receptormediated currents had completely decayed. The ratios of AMPA and NMDA amplitudes were calculated in consecutive time periods with unchanged stimulation parameters. The PPR was calculated as the average amplitude of the second of two EPSCs elicited with extracellular stimuli separated by 50 ms, divided by the average amplitude of the first EPSC in the pair. For these data, ten individual trials were analyzed and the PPR was computed from the averaged trace. Data were expressed as mean ± SEM, and p values Figure 8 . Evoked Neurotransmitter Release Increases Spinophilin Levels in Hypothalamic Neurons (A) Treatment of cultured hypothalamic neurons with estradiol significantly increases levels of spinophilin protein, and pretreatment with the estrogen receptor (ER) antagonist ICI prevents this increase. Treatment of neurons with the secretagogue a-latrotoxin to evoke neurotransmitter release recovers the effect of blocking ER and increases spinophilin to levels seen with estradiol treatment alone (ANOVA F 4,20 = 9.86; p = 0.001 compared with vehicle). ICI alone has no effect on spinophilin (p = 0.439, data not shown; n = 5-6 coverslips per group).
(B) In a separate experiment, treatment of cultured hypothalamic neurons with a-latrotoxin evokes neurotransmitter release and also increases spinophilin to the levels seen with estradiol treatment (ANOVA F 3,26 = 3.65; p < 0.05 compared with vehicle). Combined estradiol and a-latrotoxin treatment does not induce spinophilin levels that surpass those seen with either drug alone (p = 0.22; n = 6-8 per group). Graphical representation of western blot analysis indicates the mean ± SEM for each treatment group.
phosphorylation of its substrate, phospho ERK 1/2 (ANOVA F 2,12 = 6.60; *p < 0.05 compared with other groups). Estradiol had no effect on phospho ERK 1/2 at 1 hr (Veh: n = 6, E 2 1 hr: n = 5, E 2 3 hr: n = 4 animals).
(B) (Left) In the same animals from Figure 2A , estradiol treatment for 6 hr induced a 2-fold increase in the activation of MAP kinase, as seen by phosphorylation of ERK 1/2, and pretreatment with the AMPA receptor antagonist NBQX completely blocked the activation of MAP kinase (ANOVA F 3,17 = 2.96; *p < 0.05 compared with all other groups; n = 5-6 animals per group). (Right) In the same animals from Figure 2A , estradiol treatment significantly increased phosphorylation of ERK 1/2, and pretreatment with the NMDA receptor antagonist MK801 completely blocked the estradiol-induced activation of MAP kinase (F 3,17 = 4.79; *p < 0.05 compared with all other groups; n = 5-6 animals per group).
(C) (Left) Pretreatment of females with PD98059 completely blocked estradiol-induced activation of MAP kinase as seen by phosphorylation of ERK 1/2 (ANOVA F 3,16 = 7.91; *p < 0.05 compared with all other groups; n = 5 animals per group). (Right) In the same tissue, estradiol treatment significantly increased spinophilin levels, and pretreatment with PD98059 blocked the estradiol-induced increase in spinophilin in the MBH (ANOVA F 3,16 = 12.8; *p < 0.05 compared with all other groups; n = 5 animals per group). Graphical representation of FM4-64 and western blot analysis indicates the mean ± SEM for each treatment group.
were derived from Student's unpaired t test, with significance levels assessed at p < 0.05 unless otherwise noted.
Hypothalamic Cultures
Timed pregnant Sprague-Dawley female rats purchased from Charles River Laboratories (Wilmington, MA) were killed on gestational day 18. The hypothalami were dissected from the brains of approximately 8-9 fetal rats and cultured as described in Perrot-Sinal et al. (2001) . Cells were plated onto poly-L-lysinecoated glass coverslips at a density of 250,000 cells/plate with plating medium for western blot experiments and 150,000 cells/plate for imaging experiments (FM and calcium) in 2 ml of sterile culture medium (SCM). Plates were maintained in an incubator at 37 C and 5% CO 2 for 5 days in vitro before use. Plating occurred on DIV1. Culture medium was changed one time on DIV3.
Treatment of Cultured Neurons
For experiments involving FM4-64 imaging, cultures were treated for 3 or 6 hr with 10 nM 17b-estradiol or vehicle prior to imaging on DIV5. Pretreatment with antagonists such as ICI (Tocris 1 mM in DMSO), PD98059 (10 mM in DMSO), LY294002 (10 mM in DMSO), or CHX (30 mM in ethanol) occurred 30 min prior to estradiol or DMSO treatment. a-Latrotoxin (Calbiochem) was administered in saline at 3 pM in combination or separately from estradiol.
FM4-64 Imaging and Analysis
Hypothalamic neurons used for FM4-64 imaging were plated on gridded coverslips (Bellco Biotechnology), rinsed in an equilibrating buffer for 15 min, and loaded with 2 mM FM4-64 (SynaptoRed) using a loading buffer for 10 min. Immediately thereafter, neurons were washed in a rinsing buffer (see Supplemental Methods) for 10 min. Images were captured (red 600-700 nm emission filter) every 3 s to minimize photobleaching. After approximately 30 s of establishing the baseline fluorescence, the neurons were rinsed for 60 s with an unloading buffer (see Supplemental Methods) containing 50 mM KCl or stimulated at 1 Hz with an extracellular electrode placed in the bath. After $2 min of image capture during destaining, unloading of the terminals continued for another 5 min to obtain a picture of the completely destained puncta. This image was considered to represent nonspecific staining and was subtracted from all images prior to analysis. Images were analyzed using SimplePCI imaging software (Hamamatsu Inc.). The destaining rate was determined from the change in fluorescence emission over time as described in Brager et al. (2003) , Pyle et al. (1999) , and Ryan et al. (1996) . The mean total fluorescence lost from all boutons on one coverslip was averaged, and this value was then averaged with other coverslips treated identically (n = 1 coverslip, 3-4 separate culture runs per experiment). The mean total fluorescence lost was compared across treatment groups using a one-way ANOVA. Criterion for significance levels was a < 0.05. Neurons analyzed for the rate of neurotransmitter release were also analyzed for the number of loaded boutons and the area of each bouton.
Immunocytochemistry for VGLUT2
Immediately after imaging, coverslips with adhered cells were fixed and prepared for immunocytochemical detection with anti-vesicular glutamate transporter 2 (VGLUT2; Sigma, 1:1,000), then developed as described previously (Speert et al., 2007) .
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www. neuron.org/cgi/content/full/58/4/584/DC1/.
